All Type of News
Foreign-invested firms calling for withdrawal of reference pricing system
Foreign-invested pharmaceutical firms have called for the government to cautiously introduce the reference pricing system (RPS), which has been promoted by the government in a bid to ensure better finance stability in...
Drugs for gastrointestinal treatment to resume NHI coverage.
The MOHW announced the revised provisions titled "The detailed particulars pertaining to the application standards and methods for the NHI payment (the MOHW Ordinance No 2002-57, Aug. 14, 2002)" according to Article 3...
Big changes are foreseeable in hormone therapies
Market analysts say the domestic hormone therapies market is likely to shrink due to the recent announcement of the U.S. National Institute of Health that combined female hormone preparations is associated with a high...
Joint Committee urged to revise drug price determination system.
The Chronic Leukemia Patients Association and the Joint Committee for Gleevec Issue (a joint committee for the resolution of Gleevec issue and the extension of public interests to drugs) jointly took a rally in front ...
Each pharmacy charged at 140 million won on average.
The total bills charged by pharmacies amounted to 2,496,700 million won during the first half of this year, which showed about 15% up from the same period of last year, and the bill value per pharmacy was about 140 mi...
Drug-related distribution to be reformed
The MOHW intends to draft drug-related distribution reforms via e-commerce (helfline) promotion plans
The plans for the promotion of helfline were revealed at the August 8 meeting presided by Minister of Health an...
Tentative one-year implementation of minimum pricing system eyed
The Ministry of Health and Welfare (MOHW) announced that the reimbursement calculation criteria for insurance drug prices was changed from the weighed average pricing system to a minimum pricing system of actually tra...
Substitutive dispensing possible at 70% of regions across nation.
Where the common prescription drug lists are not ready as provisionally required, the substitutive dispensing with already proven drugs of efficacy equivalency may go ahead without prior physician's agreement. The cur...
Nature Publishing Group to open its R&D website sponsored by Aventis
Nature Publishing Group (NPG), a publisher of world-renowned scientific journal 'Nature', announced it opened its own R&D information website (www.nature.com/drugdisc) from this August and is now in operation. This we...
H-Pharm's Propin capsule designated as first bioequivalence test-waivered item
The Korea Food and Drug Administration (KFDA) announced that H-Pharm's antidepressant Propin capsule (fluoxetine HCl) was granted as the first bioequivalence test-waivered item, since its policy of expanding the waive...
